Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.52
HEWA's Cash to Debt is ranked higher than
69% of the 610 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.54 vs. HEWA: 0.52 )
HEWA' s 10-Year Cash to Debt Range
Min: 0.08   Max: No Debt
Current: 0.52

Equity to Asset -2.19
HEWA's Equity to Asset is ranked lower than
55% of the 602 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.43 vs. HEWA: -2.19 )
HEWA' s 10-Year Equity to Asset Range
Min: -3.62   Max: 0.78
Current: -2.19

-3.62
0.78
F-Score: 5
Z-Score: -26.88
M-Score: -6.49
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -28.28
HEWA's Operating margin (%) is ranked lower than
53% of the 612 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.46 vs. HEWA: -28.28 )
HEWA' s 10-Year Operating margin (%) Range
Min: -145.68   Max: 3.92
Current: -28.28

-145.68
3.92
Net-margin (%) -29.09
HEWA's Net-margin (%) is ranked lower than
53% of the 612 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.13 vs. HEWA: -29.09 )
HEWA' s 10-Year Net-margin (%) Range
Min: -142.82   Max: 6.86
Current: -29.09

-142.82
6.86
ROA (%) -120.07
HEWA's ROA (%) is ranked lower than
55% of the 613 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.36 vs. HEWA: -120.07 )
HEWA' s 10-Year ROA (%) Range
Min: -307.05   Max: 12.84
Current: -120.07

-307.05
12.84
ROC (Joel Greenblatt) (%) -306.29
HEWA's ROC (Joel Greenblatt) (%) is ranked lower than
54% of the 612 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 18.09 vs. HEWA: -306.29 )
HEWA' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1009.09   Max: 16
Current: -306.29

-1009.09
16
Revenue Growth (3Y)(%) -41.50
HEWA's Revenue Growth (3Y)(%) is ranked lower than
52% of the 513 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.40 vs. HEWA: -41.50 )
HEWA' s 10-Year Revenue Growth (3Y)(%) Range
Min: -62.1   Max: 84.2
Current: -41.5

-62.1
84.2
EBITDA Growth (3Y)(%) -54.70
HEWA's EBITDA Growth (3Y)(%) is ranked higher than
51% of the 475 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.90 vs. HEWA: -54.70 )
HEWA' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -79.5   Max: 98.8
Current: -54.7

-79.5
98.8
EPS Growth (3Y)(%) -50.60
HEWA's EPS Growth (3Y)(%) is ranked higher than
52% of the 432 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.50 vs. HEWA: -50.60 )
HEWA' s 10-Year EPS Growth (3Y)(%) Range
Min: -77.9   Max: 86.1
Current: -50.6

-77.9
86.1
» HEWA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with HEWA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 0.59
HEWA's P/S is ranked higher than
51% of the 676 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.60 vs. HEWA: 0.59 )
HEWA' s 10-Year P/S Range
Min: 0.28   Max: 29.23
Current: 0.59

0.28
29.23
EV-to-EBIT -4.56
HEWA's EV-to-EBIT is ranked higher than
55% of the 676 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 18.51 vs. HEWA: -4.56 )
HEWA' s 10-Year EV-to-EBIT Range
Min: -94   Max: 0.9
Current: -4.56

-94
0.9
Current Ratio 0.19
HEWA's Current Ratio is ranked lower than
54% of the 604 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.15 vs. HEWA: 0.19 )
HEWA' s 10-Year Current Ratio Range
Min: 0.14   Max: 3.42
Current: 0.19

0.14
3.42
Quick Ratio 0.16
HEWA's Quick Ratio is ranked lower than
53% of the 604 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.66 vs. HEWA: 0.16 )
HEWA' s 10-Year Quick Ratio Range
Min: 0.08   Max: 3.08
Current: 0.16

0.08
3.08
Days Inventory 28.68
HEWA's Days Inventory is ranked higher than
81% of the 676 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 41.46 vs. HEWA: 28.68 )
HEWA' s 10-Year Days Inventory Range
Min: 15.79   Max: 353.13
Current: 28.68

15.79
353.13
Days Sales Outstanding 6.01
HEWA's Days Sales Outstanding is ranked higher than
86% of the 676 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 22.05 vs. HEWA: 6.01 )
HEWA' s 10-Year Days Sales Outstanding Range
Min: 2.96   Max: 98.7
Current: 6.01

2.96
98.7

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.40
HEWA's Price/Median PS Value is ranked higher than
96% of the 676 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.30 vs. HEWA: 0.40 )
HEWA' s 10-Year Price/Median PS Value Range
Min: 0.21   Max: 12.5
Current: 0.4

0.21
12.5
Earnings Yield (Greenblatt) -36.50
HEWA's Earnings Yield (Greenblatt) is ranked lower than
59% of the 610 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.70 vs. HEWA: -36.50 )
HEWA' s 10-Year Earnings Yield (Greenblatt) Range
Min: -36.5   Max: 818
Current: -36.5

-36.5
818

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers
Compare:SHDMF, APNHF, GNC, JCOUF, PMC » details
HealthWarehouse.com Inc was incorporated in the State of Delaware on August 5, 1998. The Company is a U.S. licensed virtual retail pharmacy and healthcare e-commerce company that sells brand name and generic prescription drugs as well as over-the-counter medical products. The Company is presently licensed as a mail-order pharmacy for sales to 50 states in the United States and the District of Columbia. Currently, it sells prescription drugs both brand name and generic; diabetic supplies including glucometers, lancets, syringes and test strips; OTC medications covering allergy and sinus to pain and fever to smoking cessation aids; diet and nutritional products including supplements, weight loss aids, and vitamins and minerals and pet medications. It also provides 90-day return policy with no restocking fees, and 100% free standard shipping on all orders. It sells directly to individual consumers who purchase prescription medications and OTC products. The Company's online pharmacy offers the following advantages: Legitimacy, Convenience, Selection, Information, Privacy, Value, and Customer Service. The Company's business is centered on Internet-based advertising. The Company filed for a trademark on the name HealthWarehouse.com on August 14, 2007 with the U.S. Patent and Trademark Office, which trademark was granted with a registration date of May 19, 2009. The Company's competitors in the segment include chain drugstores, mail order pharmacies, mass market retailers, warehouse clubs and supermarkets. Federal and state laws and regulations govern many aspects of its business and are specific to pharmacies and the sale of OTC drugs.
» More Articles for HEWA

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 03 2015
HEALTHWAREHOUSE.COM, INC. Financials Apr 02 2015
HealthWarehouse.com Reports 2014 Annual Results Apr 02 2015
HEALTHWAREHOUSE.COM, INC. Files SEC form 10-K, Annual Report Mar 30 2015
HealthWarehouse.com Renews Senior Secured Debt With Melrose Capital Mar 18 2015
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Mar 11 2015
HealthWarehouse.com Responds to Senator Klobuchar & McCain On Reintroduction of Canadian Pharmacy... Jan 27 2015
HealthWarehouse.com Relaunches Website for Consumers Who Pay out of Pocket for Prescriptions Jan 07 2015
HealthWarehouse.com Reports Third Quarter 2014 Results Nov 24 2014
HEALTHWAREHOUSE.COM, INC. Files SEC form 10-Q, Quarterly Report Nov 14 2014
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial... Oct 29 2014
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Change in Directors or Principal Officers Oct 22 2014
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Oct 21 2014
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial... Aug 26 2014
HEALTHWAREHOUSE.COM, INC. Files SEC form 10-Q, Quarterly Report Aug 19 2014
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... May 30 2014
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 23 2014
HealthWarehouse.com Reports First Quarter 2014 Results May 22 2014
HEALTHWAREHOUSE.COM, INC. Files SEC form 10-Q, Quarterly Report May 16 2014
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 23 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK